tiprankstipranks
Trending News
More News >
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Technical Analysis

Compare
108 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Barinthus Biotherapeutics’s (BRNS) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Barinthus Biotherapeutics is a Sell.
Barinthus Biotherapeutics’s (BRNS) 20-Day exponential moving average is 0.63, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 50-Day exponential moving average is 0.70, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.

Barinthus Biotherapeutics (BRNS) Pivot Points

Mar 05, 2026, 01:21 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.49
0.53
0.56
0.60
0.63
0.67
0.70
Fibonacci
0.53
0.55
0.57
0.60
0.62
0.64
0.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Barinthus Biotherapeutics (BRNS) Moving Averages

Mar 05, 2026, 01:21 PM
Period
Simple
Exponential
MA5
0.59Buy
0.60Buy
MA10
0.60Buy
0.61Sell
MA20
0.63Sell
0.63Sell
MA50
0.69Sell
0.70Sell
MA100
0.84Sell
0.80Sell
MA200
1.00Sell
0.91Sell
Barinthus Biotherapeutics’s (BRNS) 10-Day exponential moving average is 0.61, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) 100-Day exponential moving average is 0.80, while Barinthus Biotherapeutics’s (BRNS) share price is $0.76, making it a Sell.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 50-day simple moving average is 0.69, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 100-day simple moving average is 0.84, creating a Sell signal.
Barinthus Biotherapeutics’s (BRNS) stock price is $0.76 and Barinthus Biotherapeutics’s (BRNS) 200-day simple moving average is 1.00, creating a Sell signal.

Barinthus Biotherapeutics (BRNS) Technical Indicators

Mar 05, 2026, 01:21 PM
Name
Value
Implied Action
RSI (14)
42.24
Neutral
STOCH (9,6)
38.67
Neutral
STOCHRSI (14)
28.96
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
28.66
Neutral
Williams %R
-71.43
Buy
CCI (14)
-58.44
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
38.95
Neutral
ROC
-9.09
Sell
Barinthus Biotherapeutics’s (BRNS) Relative Strength Index (RSI) is 42.24, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Trend Strength Indicator (ADX) is 28.66, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Commodity Channel Index (CCI) is -58.44, creating a Neutral signal.
Barinthus Biotherapeutics’s (BRNS) Price Rate of Change (ROC) is -9.09, creating a Sell signal.

FAQ

Is BRNS a Buy, Hold, or Sell?
Based on BRNS’s technical indicators, BRNS is a Sell.
    What is BRNS’s RSI (14)?
    BRNS’s RSI (14) is 42.24, which suggests BRNS is a Neutral.
      What is BRNS’s MACD?
      BRNS’s MACD is -0.03, which suggests BRNS is a Sell.
        What is BRNS’s 5-day moving average?
        BRNS’s 5-day moving average is 0.59, which suggests BRNS is a Buy.
          What is BRNS’s 20-day moving average?
          BRNS 20-day moving average is 0.63, which suggests BRNS is a Sell.
            What is BRNS’s 50-day moving average?
            BRNS’s 50-day moving average is 0.69, which suggests BRNS is a Sell.
              What is BRNS’s 200-day moving average?
              BRNS’s 200-day moving average is 1.00, which suggests BRNS is a Sell.
                What is BRNS’s Williams % R (14)?
                BRNS’s Williams % R (14) is -71.43, which suggests BRNS is a Buy.
                  What is BRNS’s CCI (14)?
                  BRNS’s CCI (14) is -58.44, which suggests BRNS is a Neutral.